Olympus is a medical device maker with a leading position in the endoscope market and a diversified global revenue stream. Originally founded in 1919 in Japan as a microscope and camera maker, Olympus has gradually pivoted into endoscopic and therapeutic solutions. As of March 2024, more than 60% of its revenue comes from endoscopic solutions. In addition, North America is the biggest revenue contributor by region, accounting for 38% of its total revenue.
1919
36.5K+
LTM Revenue $6.7B
LTM EBITDA $1.5B
$13.4B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Olympus has a last 12-month revenue of $6.7B and a last 12-month EBITDA of $1.5B.
In the most recent fiscal year, Olympus achieved revenue of $6.2B and an EBITDA of $745M.
Olympus expects next 12-month revenue of XXX   and NTM EBITDA of XXX
See Olympus valuation multiples based on analyst estimatesFY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
---|---|---|---|---|---|
Revenue | $5.9B | $6.2B | XXX | XXX | XXX |
Gross Profit | $3.8B | $4.0B | XXX | XXX | XXX |
Gross Margin | 65% | 64% | XXX | XXX | XXX |
EBITDA | $1.7B | $745M | XXX | XXX | XXX |
EBITDA Margin | 29% | 12% | XXX | XXX | XXX |
Net Profit | $769M | $953M | XXX | XXX | XXX |
Net Margin | 13% | 15% | XXX | XXX | XXX |
Net Debt | $555M | $1.1B | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Olympus's stock price is JPY 1783 (or $12).
Olympus has current market cap of JPY 2.01T (or $13.4B), and EV of JPY 2.01T (or $13.4B).
See Olympus trading valuation dataEV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
---|---|---|---|---|---|---|
$13.4B | $13.4B | XXX | XXX | XXX | XXX | $0.63 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Olympus has market cap of $13.4B and EV of $13.4B.
Olympus's trades at 2.0x LTM EV/Revenue multiple, and 9.0x LTM EBITDA.
Analysts estimate Olympus's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Olympus and 10K+ public compsFY 2024 | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|
EV | $13.4B | XXX | XXX | XXX |
EV/Revenue | 2.0x | XXX | XXX | XXX |
EV/EBITDA | 10.3x | XXX | XXX | XXX |
P/E | 14.2x | XXX | XXX | XXX |
P/E/Growth | 60.3x | XXX | XXX | XXX |
EV/FCF | 22.5x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpOlympus's NTM/LTM revenue growth is 5%
Olympus's revenue per employee for the last fiscal year averaged $0.2M, while opex per employee averaged $0.1M for the same period.
Over next 12 months, Olympus's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Olympus's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Olympus and other 10K+ public compsFY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|---|
Revenue Growth | 6% | XXX | XXX | XXX | XXX |
EBITDA Margin | 20% | XXX | XXX | XXX | XXX |
EBITDA Growth | -56% | XXX | XXX | XXX | XXX |
Rule of 40 (SaaS-only) | 25% | XXX | XXX | XXX | XXX |
Revenue per Employee | $0.2M | XXX | XXX | XXX | XXX |
Opex per Employee | $0.1M | XXX | XXX | XXX | XXX |
S&M Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
G&A Expenses to Revenue | 51% | XXX | XXX | XXX | XXX |
R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
Opex to Revenue | 62% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
EV/Revenue | EV/EBITDA | |||||
---|---|---|---|---|---|---|
2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
Philips | XXX | XXX | XXX | XXX | XXX | XXX |
Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Olympus acquired XXX companies to date.
Last acquisition by Olympus was XXXXXXXX, XXXXX XXXXX XXXXXX . Olympus acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiplesAcquired Company | EV | EV/Revenue | EV/EBITDA |
---|---|---|---|
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign UpWhen was Olympus founded? | Olympus was founded in 1919. |
Where is Olympus headquartered? | Olympus is headquartered in Japan. |
How many employees does Olympus have? | As of today, Olympus has 36.5K+ employees. |
Who is the CEO of Olympus? | Olympus's CEO is Mr. Stefan Kaufmann. |
Is Olympus publicy listed? | Yes, Olympus is a public company listed on TKS. |
What is the stock symbol of Olympus? | Olympus trades under 7733 ticker. |
When did Olympus go public? | Olympus went public in 1949. |
Who are competitors of Olympus? | Similar companies to Olympus include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
What is the current market cap of Olympus? | Olympus's current market cap is $13.4B |
What is the current revenue of Olympus? | Olympus's last 12-month revenue is $6.7B. |
What is the current EBITDA of Olympus? | Olympus's last 12-month EBITDA is $1.5B. |
What is the current EV/Revenue multiple of Olympus? | Current revenue multiple of Olympus is 2.0x. |
What is the current EV/EBITDA multiple of Olympus? | Current EBITDA multiple of Olympus is 9.0x. |
What is the current revenue growth of Olympus? | Olympus revenue growth between 2023 and 2024 was 6%. |
Is Olympus profitable? | Yes, Olympus is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.